CIDRAP Leadership Forum Infectious Disease BRIEFING
|
|
|
- Abraham Cross
- 5 years ago
- Views:
Transcription
1 Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING December 13 th, 2017
2 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
3 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
22
23
24
25
26
27
28
29
30 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
31
32
33
34
35 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
36
37
38
39
40
41
42
43
44
45
46 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
47
48
49
50 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
51
52
53
54
55
56
57
58
59 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
60
61
62 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
63
64
65
66
67
68
69 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
70
71
72
73
74 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
75
76
77
78
79
80
81
82 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
83
84
85
86 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine, antivirals) 2. Dengue vaccine 3. North Korea bioweapons UPDATES 4. Avian influenza 5. Global health security 6. Cholera and Polio 7. Global TB 8. Viral Hepatitis 9. Monkeypox 10.Zika and Chikungunya 11.Plague 12.Other (MERS, Lyme disease)
87
88
89
90
91
92
93
94 Questions, Comments and Discussion
95 Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING December 13 th, 2017 Thank you for attending!
CIDRAP Leadership Forum Infectious Disease BRIEFING
Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING August 22 nd, 2018 CLF BRIEFING HOT TOPICS 1. Ebola 2. Foodborne diseases 3.
CIDRAP Leadership Forum Infectious Disease BRIEFING August 17, 2016
Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING August 17, 2016 CLF BRIEFING 1. Vectorborne diseases Zika Yellow Fever, Chikungunya,
Classification of Infectious Disease Law in Japan
Classification of Infectious Disease Law in Japan Type 1 (7) Type 2 (7) Type 3 (5) Type 4 (44) Viral Hemorrhagic Fever EVD Lassa Fever CCHF Marburg disease South American Hemorrhagic Fevers Plague Smallpox
Infectious Diseases Weekly Report. 12 January 2018 / Number 1. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 12 January / Number 1 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Infectious Diseases Weekly Report. 23 August 2018 / Number 33. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 23 August / Number 33 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Infectious Diseases Weekly Report. 8 November 2018 / Number 44. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 8 November / Number 44 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Infectious Diseases Weekly Report. 15 November 2018 / Number 45. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 15 November / Number 45 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Infectious Diseases Weekly Report. 14 March 2019 / Number 10. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 14 March / Number 10 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Infectious Diseases Weekly Report. 22 March 2019 / Number 11. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 22 March / Number 11 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Infectious Diseases Weekly Report. 28 March 2019 / Number 12. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 28 March / Number 12 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Infectious Diseases Weekly Report. 4 April 2019 / Number 13. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 4 April / Number 13 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Infectious Diseases Weekly Report. 11 April 2019 / Number 14. The infectious diseases which all physicians must report
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 11 April / Number 14 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Killer Viruses: The Why and The How. Amesh Adalja
Killer Viruses: The Why and The How Amesh Adalja MD @AmeshAA Disclosures Stockholder: Merck, Luminex, Evolent Bondholder: UPMC Speaker s Bureau: Merck, Roche Consultant: Roche Funding: Open Philanthropy
DHHS 2124 (Revised 7/03) EPIDEMIOLOGY. Hemorrhagic Fever (68)] Causative Organism: [Encephalitis, arboviral (9), Other Foodborne Disease (13), Viral
![DHHS 2124 (Revised 7/03) EPIDEMIOLOGY. Hemorrhagic Fever (68)] Causative Organism: [Encephalitis, arboviral (9), Other Foodborne Disease (13), Viral](/thumbs/85/91700736.jpg "DHHS 2124 (Revised 7/03) EPIDEMIOLOGY. Hemorrhagic Fever (68)] Causative Organism: [Encephalitis, arboviral (9), Other Foodborne Disease (13), Viral")
Reporters should indicate in the "COMMENTS" section the source of infection, if known, particularly for foodborne diseases. This area of the card is used by State or local health department staff to identify
EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?
8 th International Conference GLOBAL HEALTH CONSORTIUM Building Alliances in Global Health Miami, May 22-25, 2018 EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? José Esparza MD, PhD - Adjunct
Our Mission. To promote healthy and safe travel by providing medicines, preventive vaccines and health counseling to a diverse group of travelers
Our Mission To promote healthy and safe travel by providing medicines, preventive vaccines and health counseling to a diverse group of travelers The Travel Clinic utilizes national and international travel
Laboratory Services and Networks Your priorities?
12th Meeting Caribbean National Epidemiologists and Laboratory Directors September 17th-19th, 2014 POS, Trinidad and Tobago Laboratory Services and Networks Your priorities? Dr Cristina Gutierrez Laboratory
Infectious Diseases Weekly Report. 14 March 2013 / Number 10
Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 14 March / Number 10 Surveillance System in Tokyo, Japan The infectious diseases which all physicians
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS APRIL 2017 Infectious viruses are a global health threat Since the approval of the first antiviral drug
Annual Summary of Reportable Diseases Ottawa County 2017
Annual Summary of Reportable Diseases County Prepared April, James Street Holland, MI 9-9 () 9- Fax () 9- www.miottawa.org/health Table of Contents Reportable Diseases Summary Click below to go directly
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS
Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS MAY 2017 1 Infectious viral pathogens are a significant global health threat to mankind 2 Since the approval
Surveillance Site Reporting Requirements for Infectious Diseases
Surveillance Site Reporting Requirements for Infectious Diseases Updated pril 2017 Training Materials produced by the Tuscarawas County Health Department utilizing the Ohio Department of Health Infectious
On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in
Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education
Corporate Leadership Forum March Briefing March 11, 2015
Center for Infectious Disease Research and Policy University of Minnesota Corporate Leadership Forum March Briefing March 11, 2015 Michael T. Osterholm, PhD, MPH McKnight Presidential Endowed Chair in
Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines
Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines 1 Vaccines: the single most effective medical intervention 2 Vaccines save lives Millions of cases
Outbreak preparedness and the NICD 24-hour hotline a review of calls made to the Hotline, and Outbreak Response Unit, July 2016-June 2017
Outbreak preparedness and the NICD 24-hour hotline a review of calls made to the Hotline, and Outbreak Response Unit, July 2016-June 2017 FIDSSA 2017 Kerrigan McCarthy, Nevashan Govender, Vivien Essel,
School and Daycare Communicable Disease Reporting Handbook
School and Daycare Communicable Disease Reporting Handbook BUILDING NAME: DISTRICT: Genesee County Health Department Mark Valacak, MPH, Health Officer Gary K. Johnson, MD, MPH, Medical Officer 630 S. Saginaw
1966 CDC assessment of US Health
Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 14 Emerging and New IDs Learning Objectives 1. Describe the threat of emerging and new infectious agents 2. Identify the contributing
AREAS OF CONCENTRATION
Dr. Shruti Mehta, Director The development of antibiotics, improved access to safe food, clean water, sewage disposal and vaccines has led to dramatic progress in controlling infectious diseases. Despite
Emerging and Re-emerging Infectious Diseases and Major Factors Contributing to their Emergence
Emerging and Re-emerging Infectious Diseases and Major Factors Contributing to their Emergence Ehsan Mostafavi; DVM, PhD Epidemiologist, Associate Professor Department of Epidemiology & Research Center
Infectious Disease Surveillance System in Korea. Byungguk Yang Korea Centers for Disease Control and Prevention
Infectious Disease Surveillance System in Korea Byungguk Yang Korea Centers for Disease Control and Prevention 1 General information About Korea About KCDC (Korea Centers for Disease Control and Prevention)
Preparing for the Unexpected
Centers for Disease Control and Prevention Center for Preparedness and Response Preparing for the Unexpected Stephen C. Redd, MD Rear Admiral, US Public Health Service Director, Center for Preparedness
Arbovirus Surveillance: Present and Future
Arbovirus Surveillance: Present and Future Duane J Gubler, ScD, FAAAS, FIDSA, FASTMH Emeritus Professor Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Chairman, Global Dengue
Multiple Choice Questions
Multiple Choice Questions 1. Which one of the following is not a viral disease? (a) Dengue (b) AIDS (c) Typhoid (d) Influenza 2. Which one of the following is not a bacterial disease? (a) Cholera (b) Tuberculosis
Progress report on emerging and re-emerging diseases including dengue and dengue haemorrhagic fever
Regional Committee for the Eastern Mediterranean Sixty-third session Provisional agenda item 3(c) EM/RC63/INF.DOC 2 Rev.2 September 2016 Introduction Progress report on emerging and re-emerging diseases
Module 5: Introduction to Stochastic Epidemic Models with Inference
Module 5: Introduction to Stochastic Epidemic Models with Inference Instructors:, Dept. Mathematics, Stockholm University Ira Longini, Dept. Biostatistics, University of Florida Jonathan Sugimoto, Vaccine
Report to the Board 6-7 June 2018
6-7 June 2018 SUBJECT: VACCINE INVESTMENT STRATEGY: SHORT LIST Agenda item: 07 Category: For Decision Section A: Introduction This report presents outcomes of the Phase II analyses for the Vaccine Investment
Implementation Manual for the National Epidemiological Surveillance of Infectious Diseases Program
Implementation Manual for the National Epidemiological Surveillance of Infectious Diseases Program Part I. Purpose and Aim The National Epidemiological Surveillance of Infectious Diseases (NESID) Program
Module 5: Introduction to Stochastic Epidemic Models with Inference
Module 5: Introduction to Stochastic Epidemic Models with Inference Instructors: Tom Britton, Dept. Mathematics, Stockholm University Ira Longini, Dept. Biostatistics, University of Florida Jonathan Sugimoto,
Risks of Emerging Infectious Diseases in ASEAN. Prasit Palittapongarnpim, M.D. Department of Microbiology, Faculty of Science, Mahidol University
Risks of Emerging Infectious Diseases in ASEAN Prasit Palittapongarnpim, M.D. Department of Microbiology, Faculty of Science, Mahidol University Despite the socio-economic progress of ASEAN and increased
Emerging Infectious Diseases Australia is not an Island
Emerging Infectious Diseases Australia is not an Island Bart Currie Global and Tropical Health Division Menzies School of Health Research, Darwin Infectious Diseases Department, Royal Darwin Hospital Borneo
VACCINES AND HYGIENE RULES
VACCINES AND HYGIENE RULES Paraguay Bolivia Argentina Paraguay, Argentina and Bolivia are not considered countries "at risk". Better safe than sorry, however, so here are a few important recommendations:
Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared?
Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared? International Conference on (Re) Emerging Infectious Diseases, 12-14 March, African Union Commission,
Understanding and Preparing for Emerging Disease Outbreaks
Understanding and Preparing for Emerging Disease Outbreaks CAPT Ha C. Tang, D.O. US Public Health Service Adjunct Associate Clinical Professor of Dartmouth Medical School, Community/Family Medicine Dept.
Global Challenges of Pandemic and Avian Influenza. 19 December 2006 Keiji Fukuda Global influenza Programme
Global Challenges of Pandemic and Avian Influenza 19 December 2006 Keiji Fukuda Global influenza Programme Summary of Current H5N1 Situation 1997 First known outbreak infecting humans 18 people hospitalized
Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home
Center for Global Health CDC Global Health Saving Lives Overseas, Protecting Americans at Home CDC Overview Part of the U.S. Department of Health and Human Services, CDC is the nation s leading public
PREventing EMerging Pathogenic Threats (PREEMPT) Proposers Day
PREventing EMerging Pathogenic Threats (PREEMPT) Proposers Day Dr. Jim Gimlett, Program Manager DARPA Biological Technologies Office (BTO) January 30, 2018 Arlington, VA PREEMPT Agenda Proposers Day Objectives
Florida Department of Health - Polk County Weekly Morbidity Report - Confirmed and Probable cases * Week #9 (through March 3, 2018)
Florida Department of Health - Polk County Weekly Morbidity Report - Confirmed and Probable cases * Week #9 (through March 3, 2018) Weekly Cumulative (YTD) Annual Totals ICD 9 code Disease Category 2018
MONTHLY NOTIFIABLE DISEASE SURVEILLANCE REPORT
ISSN 2324-254X April 2018 MONTHLY NOTIFIABLE DISEASE SURVEILLANCE REPORT Data contained within this monthly report is based on information recorded on EpiSurv by Public Health Service (PHS) staff at 11
A conversation with Michael Osterholm on July 30, 2013 about pandemics
A conversation with Michael Osterholm on July 30, 2013 about pandemics Participants Michael Osterholm Director, Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota Alexander
Risk assessment group (RAG), between
Risk assessment group (RAG), between event identification and risk management. How is Belgium dealing with a crisis? Sophie Quoilin, MD SsID, 21 May 2015 Brussels Rue Juliette Wytsmanstraat 14 1050 Brussels
Acute Febrile Ilness. Brazil Marilda M Siqueira National Influenza Center/MoH, WHO National MR Laboratory/MoH,WHO
Acute Febrile Ilness Brazil - 2019 Marilda M Siqueira National Influenza Center/MoH, WHO National MR Laboratory/MoH,WHO Introduction Aetiology of fever in Brazil- range of viruses and bacteria as elsewhere.
BIOLOGICAL DIVERSITY: VIRUSES
BIOLOGICAL DIVERSITY: VIRUSES Viruses: a Group of Intracellular Parasites In the 19th century, many rabies cases plagued Europe. In London, for example, 29 deaths by "hydrophobia" were enumerated in the
Objectives: To share experiences and barriers to adult vaccination in Latin American countries
Group 3 Coordinator: Dr.Roberto A. Lourenco Dr. Carlos Alberto Cano Gutiérrez - Colombia Dr. Oscar Chávez Espinosa. Nicaragua Dr. Jaime Torres. Venezuela Mr. Mark Partridge. IFA Dr. José Luis Díaz Ortega.
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report July 2016 Report Description Reportable Events among all beneficiaries received from the Services over the past 5 years are used to create ranges
HPSC - Weekly Infectious Disease Report
HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 22, 2018 (Notification
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report
DEPARTMENT OF DEFENSE AFHSB Reportable Events Monthly Report May 2016 Report Description Reportable Events among all beneficiaries received from the Services over the past 5 years are used to create ranges
HPSC - Weekly Infectious Disease Report
HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 38, 2018 (Notification
Clark County Combined Health District 2018 Annual Communicable Disease Report
Clark County Combined Health District 2018 Annual Communicable Disease Report Communicable Disease Summary 2018 In 2018, Clark County experienced a 24.2% increase in the number of communicable disease
HPSC - Weekly Infectious Disease Report
HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 49, 2018 (Notification
HPSC - Weekly Infectious Disease Report
HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 33, 2018 (Notification
HPSC - Weekly Infectious Disease Report
HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 50, 2018 (Notification
FY 2008 Appropriations for R&D and Public Health Programs (in millions)
FY 2008 Appropriations for R&D and Public Health Programs (in millions) AGENCY PROGRAM FY 2008 Appropriations Status: http://thomas.loc.gov/home/approp/app08.html FY 2008 : http://www.whitehouse.gov/omb/budget/fy2007/
HPSC - Weekly Infectious Disease Report
HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 39, 2018 (Notification
Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA
Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA Technical Advisor, United States Agency for International Development (USAID) Chair, WONCA Working
HPSC - Weekly Infectious Disease Report
HPSC - Weekly Infectious Disease Report Statutory Notifications of Infectious Diseases reported in Ireland via the Computerised Infectious Disease Reporting (CIDR) system for: Week 3, 2019 (Notification
BIOLOGICAL DIVERSITY: VIRUSES
BIOLOGICAL DIVERSITY: VIRUSES Viruses: a Group of Intracellular Parasites In the 19th century, many rabies cases plagued Europe. In London, for example, 29 deaths by "hydrophobia" were enumerated in the
The Public Health Response to Emerging and Pandemic Diseases
Centers for Disease Control and Prevention The Public Health Response to Emerging and Pandemic Diseases Anne Schuchat, MD (RADM, USPHS) Acting Director, Centers for Disease Control & Prevention Acting
Events detected by national surveillance system (see Annex 1)
WHA58.3 ANNEX 2 DECISION INSTRUMENT FOR THE ASSESSMENT AND NOTIFICATION OF EVENTS THAT MAY CONSTITUTE A PUBLIC HEALTH EMERGENCY OF INTERNATIONAL CONCERN Events detected by national surveillance system
Health Questionnaire
Health Questionnaire The information collected in this document is solely for the purpose of obtaining that which is required under the Ambulance Act of Ontario and is a condition of employment for all
HEALTH REQUIREMENTS AND SERVICES: FFAD COMMUNICABLE DISEASES (EXHIBIT) REQUIREMENTS FOR EXCLUDING STUDENTS AND REPORTING CONDITIONS
REQUIREMENTS FOR EXCLUDING STUDENTS AND REPORTING CONDITIONS The information on the chart below has been collected from Department of Health rules at 25 TAC 97.3, 97.6, 97.7, and 97.132 The major criterion
A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES
A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES Since 1888, date of its creation, has been committed to contain infectious diseases by working directly in regions where
President's FY 2009 Budget Request for R&D and Public Health Programs
Request for R&D and Public Health Programs (in millions) : http://www.whitehouse.gov/omb/budget/fy2007/ FY Final Appropriations: http://thomas.loc.gov/home/approp/app08.html FY Levels based on Documents
Epidemics, pandemics and how to control them. Christopher Whitty Gresham College 2018
Epidemics, pandemics and how to control them. Christopher Whitty Gresham College 2018 In Sir Thomas Gresham s lifetime (c1519-1579) infectious diseases dominated medicine. Many were a constant presence,
Second China-U.S. Workshop on the Challenges of Emerging Infections, Laboratory Safety and Global Health Security
Second China-U.S. Workshop on the Challenges of Emerging Infections, Laboratory Safety and Global Health Security May 17-19 2017, Wuhan, China Meeting Program Note: Each report will take 25 minutes including
Looking forward based on past experiences: What s old is new again
Looking forward based on past experiences: What s old is new again International Conference on (Re-)Emerging Infectious Diseases March 12, 2018 Rebecca Martin, PhD Director of the Center for Global Health
UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI
UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI OUTLINE PRESENTATION Historical perspective Vision, Mission, Core values Functions of UVRI and achievements HISTORIC PERSPECTIVE Established in 1936
CONTACTS & ACKNOWLEDGEMENTS
CONTACTS & ACKNOWLEDGEMENTS Snohomish Health District Communicable Disease Surveillance and Response Analysis and publication: Hollianne Bruce, MPH Program Manager: Amy Blanchard, RN, BSN Communicable
Presentation Overview
COMMUNICABLE DISEASE SURVEILLANCE IN VIETNAM: CURRENT SITUATIONS AND CHALLENGES ARF WORKSHOP ON DISEASE DETECTION AND SURVEILLANCE 13-15, September 2011, Manila, Philippine Tran Nhu Duong, MD National
IVI STRATEGY ARTICULATION. October 12, 2015
IVI STRATEGY ARTICULATION October 12, 2015 Overall messages for today Our Vision and Mission are as relevant today as they have ever been We need to focus on the diseases and activities where we can have
SPPH Control of Communicable Diseases January - April 2018
SPPH 520 - Control of Communicable Diseases January - April 2018 TIME: LOCATION: INSTRUCTORS: OFFICE: ASSISTANT: Mondays, 9:00AM- 12:00PM Room 143, School of Population and Public Health Bldg Dr. David
Combating Agent X: Accelerating Global Vaccine Production Against New Pandemic Threats
Combating Agent X: Accelerating Global Vaccine Production Against New Pandemic Threats Dr. George Poste Chief Scientist, Complex Adaptive Systems Initiative and Del E. Webb Chair in Health Innovation Arizona
Public Health Perspectives: Coordination the Response to Imported Infectious Disease Threats in New York City
Public Health Perspectives: Coordination the Response to Imported Infectious Disease Threats in New York City Marci Layton, MD New York City Department of Health Factors leading to (re-)emergence of new
Session 44 PD, Pestilence: Getting to Know the Fourth Horseman. Moderator: Jean Marc Fix, FSA, MAAA. Presenters: Martin Meltzer, Ph.D.
Session 44 PD, Pestilence: Getting to Know the Fourth Horseman Moderator: Jean Marc Fix, FSA, MAAA Presenters: Jean Marc Fix, FSA, MAAA Martin Meltzer, Ph.D. SOA Antitrust Disclaimer SOA Presentation Disclaimer
MONTHLY NOTIFIABLE DISEASE SURVEILLANCE REPORT
ISSN 2324-254X November 2017 MONTHLY NOTIFIABLE DISEASE SURVEILLANCE REPORT Data contained within this monthly report is based on information recorded on EpiSurv by Public Health Service (PHS) staff at
Lecture 2 Evolution in action: the HIV virus
Lecture 2 Evolution in action: the HIV virus Peter and Rosemary Grant Barry Sinervo The HIV/AIDS pandemic Life expectancy in Botswana What is HIV? What is HIV? HIV is a retrovirus (i.e., RNA-based) with
Weekly Influenza Activity: Statistics Summary
Weekly Influenza Activity: Statistics Summary 2010-11 updated 9/9/11 Summary of the 2010-11 Influenza Season Since the start of the influenza season, 215 schools reported outbreaks of ILI. Influenza Activity
Weekly Influenza & Respiratory Activity: Statistics Summary
Weekly Influenza & Respiratory Activity: Statistics Summary 2011-12 updated 7/12/12 Influenza Activity in Minnesota Summary of the 2011-12 Season Since the start of the influenza season, 552 people were
USG Policy Perspectives on Global Influenza
USG Policy Perspectives on Global Influenza IOM Committee for the Assessment of DoD-GEIS Influenza Surveillance & Response Programs Ms. Ellen P. Embrey Deputy Assistant Secretary of Defense Force Health
Present State and Measures against Infectious Diseases in Tokyo
Asian Network of Major Cities 21 Asian Infectious Disease Project Present State and Measures against Infectious Diseases in History of Law on Infectious Diseases Revisions 1897 1999 23 Communicable Disease
Disease Prevention, Detection & Response During Public Health Emergencies
Centers for Disease Control and Prevention Disease Prevention, Detection & Response During Public Health Emergencies Tom Frieden, MD, MPH Director, Centers for Disease Control and Prevention Global Disaster
Page 1 of 5 For Immediate Release Office of the Press Secretary July 17, 2007 Fact Sheet: Implementation of the National Strategy for Pandemic Influenza A One-Year Summary Of Efforts To Better Protect
CHINESE INFORMATION SYSTEM FOR INFECTIOUS DISEASES CONTROL AND PREVENTION. Center for Public Health Surveillance and Information Services, China CDC
CHINESE INFORMATION SYSTEM FOR INFECTIOUS DISEASES CONTROL AND PREVENTION Center for Public Health Surveillance and Information Services, China CDC PREFACE 2003 SARS (VPN) In 2003, a precipitate disaster
LARRY M. BUSH, MD, FACP
ZIKA VIRUS UPDATE 2016 LARRY M. BUSH, MD, FACP Affiliated Professor of Clinical Biomedical Sciences Charles E. Schmidt College of Medicine Florida Atlantic University Affiliate Associate Professor of Medicine
Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS
Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS 8-9 December 2015 Executive summary On 8-9 December,
Avian Influenza and Other Communicable Diseases: Implications for Port Biosecurity
Avian Influenza and Other Communicable Diseases: Implications for Port Biosecurity David Kim, MD, MA Division of Global Migration and Quarantine Centers for Disease Control and Prevention Atlanta, GA July
Avian Influenza and Zoonotic Influenza -in the context of pandemic preparedness-
Avian Influenza and Zoonotic Influenza -in the context of pandemic preparedness- Kazutoshi Nakashima, MD, PhD National Institute of Infectious Diseases Infectious Disease Surveillance Center Impact of
Health Information For International Travel, [Paperback] By The Centers for Disease Control and Prevention - CDC
![Health Information For International Travel, [Paperback] By The Centers for Disease Control and Prevention - CDC](/thumbs/71/66209879.jpg "Health Information For International Travel, [Paperback] By The Centers for Disease Control and Prevention - CDC")
Health Information For International Travel, 2001-2002 [Paperback] By The Centers for Disease Control and Prevention - CDC If you are searched for the book by The Centers for Disease Control and Prevention
2017 Communicable Diseases Data Brief
217 Communicable Diseases Data Brief Highlights In 216, the most commonly-occurring communicable diseases in Guilford County were sexually transmitted infections (STIs), with chlamydia contributing the
Advanced Molecular Detection: An Overview
Advanced Molecular Detection: An Overview Gregory Armstrong, MD Director Office of Advanced Molecular Detection National Center for Emerging and Zoonotic Infectious Diseases Office of Advanced Molecular